Here we evaluated the effects of immunization with a DNA vaccine encoding fusion protein consisting of macrophage inflammatory protein-1 ␣(MIP-1␣) and MPT51 (a major secreted protein from Mycobacterium tuberculosis) on induction of specific CD8+ T cells. Tetramer assay revaled that the DNA vaccine encoding the fusion protein could induce significantly higher number of the antigen specific CD8+ T-cells in mice than DNA vaccine encoding MPT51 alone. Also, splenocytes from mice immunized with the fusion DNA vaccine expressed higher level of IFN-␥ mRNA and protein upon stimulation with an epitope peptide derived from MPT51 than those from mice immunized with a mixture of two DNA vaccines encoding either MPT51 or MIP-1␣.
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Methods &. Results: Here we evaluated the effects of immunization with a DNA vaccine encoding fusion protein consisting of macrophage inflammatory protein-1 ␣(MIP-1␣) and MPT51 (a major secreted protein from Mycobacterium tuberculosis) on induction of specific CD8+ T cells. Tetramer assay revaled that the DNA vaccine encoding the fusion protein could induce significantly higher number of the antigen specific CD8+ T-cells in mice than DNA vaccine encoding MPT51 alone. Also, splenocytes from mice immunized with the fusion DNA vaccine expressed higher level of IFN-␥ mRNA and protein upon stimulation with an epitope peptide derived from MPT51 than those from mice immunized with a mixture of two DNA vaccines encoding either MPT51 or MIP-1␣.
Conclusion: These results suggest that DNA vaccine encoding MIP-1␣-antigen fusion protein is able to be efficiently internalized into antigen-presenting cells via the chemokine receptor and induce higher level of antigen specific CD8+T cell responses. Background: Mycobacterium tuberculosis is the leading cause of death from a single bacterial species in the world and in its host macrophage is subjected to a highly oxidative environment and consequently has evolved protection mechanisms against reactive oxygen and nitrogen intermediates. Alkyl hydroperoxidase D (AhpD) is a molecule from these mycobacterial defense systems that has a dual function. It not only works with Alkyl hydroperoxidase C (AhpC) in mycobacterial defense system against Oxidative stress but also has a role in oxidation/reduction of succinyltransferase B (SucB), dihydrolipoamide dehydrogenase(LPD) and AhpC. As known inhibitors of AhpD, do not completely suppress the in vitro activity of AhpC/AhpD, using competitive precursor for AhpD could not inactivate the AhpC/AhpD complex and little is known about the effects of site specific mutagenesis in ahpD gene in the persistence of Mycobacterium bovis Bacillus Calmette-Guerin(BCG) in infected Macrophages
Results: We did site specific mutagenesis in Mycobacterium bovis BCG and evaluate the effects of this mutagenesis in intracellular persistence of wild type BCG strains and ahpD mutant ones by comparing Colony Forming Units(CFU) of macrophage culture lysates infected by these strains. Our results showed a sever decrease in the CFU's of ahpD mutant BCG strains in comparison with wild type bacteria.Also our finding showed that ahpD mutant strains can grow in ordinary mycobacterial media only in the presence of supplementary materials. Introduction: Various studies have revealed that the anti-PPD T cell response in tuberculosis patients is biased towards the T-helper 2 (Th2) type. However, the mechanism by which Mycobacterium tuberculosis establish a Th2 response is not clearly known. The interleukin-12 (IL-12) is known to activate the Th1 T-cell response and therefore, inhibition of IL-12 production by M. tuberculosis is likely to induce a Th2 response. Interestingly, an attempt to monitor gene expression patterns of mycobacteria residing within macrophages revealed up-regulation of M. tuberculosis heat shock (Mtbhsp60) protein suggesting that this might offer a survival advantage to mycobacteria within the host. Again, immunization of mice with Mtbhsp60 protects them when challenged with M. tuberculosis suggesting that Mtbhsp60 may be involved in M. tuberculosis pathogenesis. Therefore, in this study, we have examined whether Mtbhsp60 inhibits IL-12 induction in macrophages and skews the anti-PPD T cell response towards the Th2 type.
Methods: PBMC from heparinized blood samples were isolated using nylon wool, IL-12p40/IL-10 levels were estimated by two-site sandwich ELISA, Western blotting and EMSA was used to check the levels of c-rel, p65 and p50 NF-kB, transient transfection, Flow cytometric analysis and Immunoflourescene were used Results: We demonstrate that Mtbhsp60 skews the anti-PPD T-cell response towards the Th2 type. We further demonstrated that the Mtbhsp60 inhibited IL-12p40 induction in response to PPD. Mtbhsp60 upregulated both p65 and p50 NF-B but inhibited c-rel transcription factor. Over-expression of c-rel in macrophages restored Mtbhsp60 mediated inhibition of IL-12p40 indicating that Mtbhsp60 targeted c-rel signaling to inhibit IL-12p40 in PPD-activated macrophages. Interestingly, we found that Mtbhsp60 utilizes the toll like receptor (TLR) 2 to inhibit IL-12 since blocking of TLR2 by using either anti-TLR2 neutralizing antibody or TLR2 siRNA resulted in up-regulation of both nuclear c-rel and IL-12p40 levels.
Conclusion: The involvement of Mtbhsp60 in pushing the balance to a Th2 response has therapeutic implications. doi:10.1016/j.ijid.2008.05.1355 
